CytomX Therapeutics (CTMX) EBITDA Margin Growth (5y) (2019 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | CytomX Therapeutics | 638.18 Mn | 291.48 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 10,656.00 |
| Dec 31, 2025 | -104,348.00 |
| Sep 30, 2025 | 9,869.00 |
| Jun 30, 2025 | 36,597.00 |
| Mar 31, 2025 | 936.00 |
| Dec 31, 2024 | 84,788.00 |
| Sep 30, 2024 | 23,945.00 |
| Jun 30, 2024 | 29,381.00 |
| Mar 31, 2024 | 11,323.00 |
| Dec 31, 2023 | 28,373.00 |
| Sep 30, 2023 | 19,852.00 |
| Jun 30, 2023 | 13,096.00 |
| Mar 31, 2023 | 9,615.00 |
| Dec 31, 2022 | -4,178.00 |
| Sep 30, 2022 | -21,520.00 |
| Jun 30, 2022 | 5,685.00 |
| Mar 31, 2022 | -28,978.00 |
| Dec 31, 2021 | -9,119.00 |
| Sep 30, 2021 | 8,982.00 |
| Jun 30, 2021 | 15,323.00 |
| Mar 31, 2021 | 43,174.00 |
| Dec 31, 2020 | 24,222.00 |
| Sep 30, 2020 | 27,641.00 |
| Jun 30, 2020 | -8,286.00 |
| Mar 31, 2020 | 39,391.00 |
| Dec 31, 2019 | -54,113.00 |
| Sep 30, 2019 | -3,475.00 |